Navigation Links
AtheroNova Signs Agreement for Development of Clinical Trial Supplies
Date:4/25/2012

and a-80 bed Phase 1 Unit in Changchun, Jiling Province China.  Frontage has an AALAC certified preclinical animal facility in Pennsylvania, where it also maintains bioanalytical and CMC facilities. In Shanghai and Beijing, China, the company also operates bioanalytical and CMC facilities.  The Frontage CMC Division provide services in the areas of custom API synthesis and GMP manufacturing, analytical testing, formulation development and manufacturing of clinical trial materials including Sterile (Injection and Ophthalmic), Oral Solid (IR and CR), Topical, and High Potent products.  As a rapidly expanding CRO with ten years of success providing high-quality GXP services, Frontage has established an international standard in pharmaceutical product research, development, quality and management systems.

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the Company's product shipments, suitability of the compound for its intended use, mechanisms of action, clinical trials and supply chain as well as the development of applications for AtheroNova's technology. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as significant fluctuations in expenses associated with clinical trials, failure to secure additional financing, the inability to complete regulatory filings with the Food and Drug Administration, the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other infor
'/>"/>

SOURCE AtheroNova Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Agrees With AtheroNovas Clinical Development Plan as Proposed
2. AtheroNova Completes Successful Pre-IND Meeting with FDA on AHRO-001
3. HealthyWomen Asks: Do You Know the Signs and Symptoms of von Willebrand Disease (VWD)?
4. Sunpeaks Ventures Signs Advertising and Promotion Agreement With Another Major Sports Team - Clotamin To Be Sold at All Walgreens Locations Throughout Arizona
5. Fortis Healthcare Signs Agreement Giving Indias Fastest-Growing Hospital Chain Access to Masimos State-of-the-Art Noninvasive Patient Monitoring Solutions
6. Tarsa Therapeutics Signs Commercial Supply Agreement for its Ostora™ Oral Calcitonin Product With QS Pharma
7. Altitude Organic New Dispensary Counter-Space Acquisition Program - Zazzz™ - Signs Premier Location
8. Universal Capital Management Signs Letter of Intent to Purchase ProShield™ Assets
9. QRxPharma Signs License and Option Agreement with Actavis
10. Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China
11. The Centers for Disease Control & Prevention Signs Vaccine Warehouse and Distribution Contract with Sentry BioPharma Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , August 4, 2015 ... report with market overview, trends, DRO analysis, market ... developments, competitive scenario and top competitor profiles in: ... Testing Market Development and Demand Forecast to ... , Explore full reports with detailed ...
(Date:8/4/2015)... 2015 Organovo Holdings, Inc. (NYSE MKT: ... delivering scientific and medical breakthroughs using 3D bioprinting ... Paul Gallant as its General Manager ... business. Mr. Gallant has more than 20 years of ... industry, most recently serving as chief operating officer ...
(Date:8/4/2015)... , Aug. 04, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... to their offering. This report ... in veterinary medicine and pharmaceuticals as well as ... is important in the application of biotechnology to ...
Breaking Medicine Technology:Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 2Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 3Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 4Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 5Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 2Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 3Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 3
... WIRE)--May 30, 2007 - INNOVIVE Pharmaceuticals,Inc. (OTCBB: ... a Phase I,trial of INNO-406, an orally ... or,treatment-intolerant chronic myelogenous leukemia, will be,presented at ... Annual,Meeting. The meeting takes place June 1- ...
... from various,clinical studies including a pivotal Phase III trial ... Nexavar (sorafenib) tablets will be presented at the Annual,Meeting ... USA from June 1 - 5, 2007. , On ... be held on June 4, 2007. Starting at around ...
Cached Medicine Technology:Innovive Pharmaceuticals to Present Interim Data from Phase I Study,of INNO-406 at the American Society of Clinical Oncology Annual,Meeting 2
(Date:8/4/2015)... ... ... How cool is it to check in at your favorite place and ... will soon allow you to do just that. , Ahhaa is releasing the next ... feature. , Users will soon get to share what inspires them about their favorite ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... it has joined the American Association of Tissue Banks (AATB) as an Affiliate ... its mission “to honor donors, and to save and improve lives by promoting ...
(Date:8/4/2015)... FL (PRWEB) , ... August 04, 2015 , ... ... testing organization which provides vascular, electrocardiogram (EKG), echocardiogram, and NCV testing, announced their ... has been successfully identifying previously undiagnosed cardiovascular abnormalities one program at a time. ...
(Date:8/4/2015)... ... 2015 , ... Angelina Jolie is in it at age 39. “It” is ... Dr. Angela DeRosa, DO, MBA, CPE aka “Dr. Hot Flash,” arguably the Southwest’s ... of menopause. , Myth #1: Menopause only affects old ladies. – Menopause can ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... Food,” scheduled for Nov. 3 – 4, 2015, at UC San Diego, will ... new businesses, improve food access, and manage resources efficiently against the dueling backdrop ...
Breaking Medicine News(10 mins):Health News:Ahhaa App Soon to Release the "Now" Feature 2Health News:Exsurco Medical Joins AATB as Affiliate Member 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 3Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3
... by researchers at Columbia University,s Mailman School of Public ... children of a group of ubiquitous chemicals known as ... known to disrupt the endocrine system, and are widely ... household building materials, to shampoos. Recent studies of ...
... Psychogenic non-epileptic seizures may go undiagnosed for much longer in ... in the September 6, 2011, print issue of Neurology ... This type of seizure is different from seizures related to ... "People with psychogenic seizures are often diagnosed with epilepsy and ...
... in the Archives of General Psychiatry suggest that certain variants ... related to mood), may serve as a useful predictor of ... a trauma. "One of the critical questions surrounding ... the disorder following a trauma, while others appear to be ...
... Mann HealthDay Reporter , MONDAY, Sept. 5 ... are receiving their recommended vaccines, which could indicate that ... States. "We are getting better, but we still ... Rodewald, director of the immunization services division at the ...
... 5 (HealthDay News) - Rudeness among co-workers can have negative ... shows. Researchers from Baylor University found people who endure ... which can have negative effects on their family and marriages ... that when employees go home stressed and distracted, their partners ...
... , This press release is available in French ... by the European College of Neuropsychopharmacology (ECNP) sheds new light ... study finds reveal that mental disorders have become Europe,s largest ... that the majority of mental disorders remain untreated. Taken together ...
Cached Medicine News:Health News:Prenatal exposure to phthalates linked to decreased mental and motor development 2Health News:Non-epileptic seizures may be misdiagnosed longer in veterans 2Health News:The search for predictors of risk for PTSD 2Health News:More U.S. 'Tweens' Getting Recommended Vaccines 2Health News:More U.S. 'Tweens' Getting Recommended Vaccines 3Health News:Boorish Co-Workers Can Damage Your Home Life 2Health News:The size and burden of mental disorders in Europe 2Health News:The size and burden of mental disorders in Europe 3
Adson bipolar forceps, 12 cm, straight....
Bipolar foot activated forceps....
Olsen bayonet forceps, designed by Mr. Olsen in a configuration with 3 holes to make them lighter, more flexible, and also to ensure maximum grip for different procedures where there is limited acces...
Bayonet fine, smooth - 1/box....
Medicine Products: